Market Tracker

07/25 4:45pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

15.00
Delayed Data
As of Jul 25
 -0.32 / -2.09%
Today’s Change
12.84
Today|||52-Week Range
32.49
-37.91%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close15.32
Today’s open15.38
Day’s range14.95 - 15.49
Volume429,867
Average volume (3 months)726,907
Market cap$589.8M
Dividend yield--
Data as of 4:00pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+10.69%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...+0.17+3.79%
PDLIPDL BioPharma Inc-0.04-1.14%
EPZMEpizyme Inc-0.06-0.60%
HRTXHeron Therapeutics I...-0.13-0.78%
Data as of 4:00pm ET, 07/25/2016

Financials

Last reporting dateJuly 25, 2016
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts